金沙app
The Board has adopted a progressive dividend policy, intending to maintain or grow the dividend each year but, recognising that some earnings fluctuations are to be expected, the annual dividend will reflect the Board’s view of the earnings prospects over the entirety of the investment cycle.
金沙app
The Board’s aim is to continue to strike a balance between the interests of the business, financial creditors and the Company’s shareholders. After providing for investment in the business, supporting the progressive dividend policy and maintaining a strong, investment-grade credit rating, the Board will keep under review potential investment in immediately earnings-accretive, value-enhancing opportunities.
金沙app
Dividends will normally be paid twice a year, with a greater proportion paid as a second interim.
- First interim: announced with second quarter and half year results and paid in September
- Second interim: announced with fourth quarter and full year results and paid in March
金沙app
To calculate the value of your forthcoming/latest dividend payment, or to look-up previous payments, please use the dividend calculator.
金沙app
Exchange rates used to convert dividend payments, announced in USD, GBP and SEK are based on the rates on the day prior to the dividend announcement.
金沙app
Please refer to the dividend FAQ for common questions regarding dividend payments.
Most recent dividend announcement
金沙app
The second interim dividend 2019 announced on Friday 14 February 2020.
Dividend dates |
|
|
Ex dividend date (Ordinary Shares & American Depositary Shares) |
|
27 February 2020 |
Record date |
|
28 February 2020 |
Payment date |
|
30 March 2020 |
Dividend rates |
|
|
GBP |
|
1.464 |
USD |
|
1.90 |
SEK |
|
18.32 |
*For holders of American Depositary Shares (ADSs) this equates to $0.95 per ADS.
Following the ratio change to the Company’s NYSE-listed sponsored Level 2 American Depositary Receipt programme on 27 July 2015, two ADSs equal one Ordinary Share.
-
金沙app
Our Annual Report provides a wide range of information about our global business.
-
金沙app
Our pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development
-
金沙app
Answers to frequently asked shareholder questions.